10.10.2011 • NewsKenneth FrazierPeopleMerck & Co.

Kenneth Frazier To Succeed Richard Clark as Merck & Co. Chair

Merck and Co. announced the retirement of its Chairman Richard Clark, effective Dec. 1. Kenneth Frazier, president of chief executive officer will succeed as chairman.

Clark has been with the company since 1972 and served as chairman since 2007. He was president and chief executive officer from 2005 through 2010. From the role of quality control inspector, he progressed through increasingly responsible roles. He left the company to join Merck-Medco Managed Care subsidiary as executive vice president and chief operating officer. He later became the chairman, president and chief executive officer of Medco Health Solutions. In 2003 Clark rejoined Merck as president of manufacturing division.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.